SS Innovations International, Inc. has released their company presentation for June 2025, providing an insight into their growth and advancements over the past year.
The company has reported significant growth in various aspects of their operations. As of June 2025, they have performed over 4,000 multi-specialty surgeries, with more than 200 robotic cardiac surgeries. This marks a substantial increase from the 100+ validated surgical procedures and 20 robotic cardiac surgeries reported in the previous year.
Additionally, the number of SSI Mantra Systems installed has increased from 93 to 1191, showing a substantial surge in the adoption of their proprietary surgical robotic system.
In terms of financial performance, SS Innovations International, Inc. has reported a notable increase in annual revenue, with figures rising from $24 million in 2023 to $78 million in 2024. This represents a significant jump in their financial standing over the past year.
Furthermore, the company's market cap has surged to $1.2 billion as of May 29, 2025, from an undisclosed previous figure, indicating a substantial increase in their market valuation.
The leadership and board of SS Innovations International, Inc. have also evolved, with key appointments and notable individuals contributing to the company's growth and success.
The company's advancements in its advanced surgical robotics technology platform are evident, with significant developments in their intellectual property, including granted utility patents and filed patent applications. Notably, the company has introduced the SSi Mantra 3, a surgical command center, patient side robotic arm carts, and a vision cart, reflecting their commitment to innovation and technological advancement.
Moreover, SS Innovations International, Inc. has made significant progress in their tele surgery capabilities, introducing the SSI Mantra M – Tele Surgery Mobile Unit and the SSI Sutra – Centralized Data Registry System, showcasing their commitment to democratizing access to robotic surgery and streamlining surgical workflows.
The company's differentiated product offering, including optimal cost-effectiveness and cardiac surgery capabilities, has positioned them as a strong player in the industry, with a range of advantages over leading brands in the market.
With a growing addressable market and favorable industry tailwinds, SS Innovations International, Inc. is poised for continued growth and success in the surgical robotics technology sector.
Today the company's shares have moved -4.67% to a price of $5.71. For more information, read the company's full 8-K submission here.
